|
TMEM56 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40269999999265E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.013950E-04 |
| Normal-vs-Stage2 |
9.70740000000303E-05 |
| Normal-vs-Stage3 |
6.019800E-02 |
| Normal-vs-Stage4 |
2.659500E-02 |
| Stage1-vs-Stage2 |
7.697600E-02 |
| Stage1-vs-Stage3 |
3.290400E-02 |
| Stage1-vs-Stage4 |
4.007800E-01 |
| Stage2-vs-Stage3 |
3.216700E-03 |
| Stage2-vs-Stage4 |
2.889700E-02 |
| Stage3-vs-Stage4 |
4.224800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.832700E-04 |
| Normal-vs-AfricanAmerican |
2.522300E-02 |
| Normal-vs-Asian |
7.000100E-02 |
| Caucasian-vs-AfricanAmerican |
7.005200E-01 |
| Caucasian-vs-Asian |
2.414200E-01 |
| AfricanAmerican-vs-Asian |
2.241800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.097300E-03 |
| Normal-vs-Female |
8.15800000000255E-05 |
| Male-vs-Female |
3.751200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.8382000000008E-05 |
| Normal-vs-Age(41-60Yrs) |
1.839190E-03 |
| Normal-vs-Age(61-80Yrs) |
7.608900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.831600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.676200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.271600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.831910E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.189000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.133600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.562400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.476700E-03 |
| Classical-VS-Follicular |
2.535900E-03 |
| Classical-VS-Other |
6.497800E-01 |
| Classical-VS-Normal |
4.031800E-04 |
| Tall-VS-Follicular |
3.5168000001029E-07 |
| Tall-VS-Other |
3.359800E-01 |
| Tall-VS-Normal |
5.470800E-01 |
| Follicular-VS-Other |
6.359600E-01 |
| Follicular-VS-Normal |
1.68499999508853E-08 |
| Other-VS-Normal |
2.740200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68160000000506E-05 |
| Normal-vs-N1 |
1.649770E-01 |
| N0-vs-N1 |
2.590000E-02 |
|
|
